Risks of testosterone replacement therapy in ageing men

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Expert Opinion on Drug Safety

• Publication date

  2004-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14740338.3.6.599PMID 15500418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function.

  2004cited by this paper
• MEDICAL PROGRESS: RISKS OF TESTOSTERONE REPLACEMENT THERAPY AND RECOMMENDATIONS FOR MONITORING

  2004cited by this paper
• An integrative review on current evidence of testosterone replacement therapy for the andropause.

  2003cited by this paper
• AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function.

  2003cited by this paper
• Delivery of testosterone replacement therapy.

  2003cited by this paper
• Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan.

  2003cited by this paper
• The short-term effects of high-dose testosterone on sleep, breathing, and function in older men.

  2003cited by this paper
• Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.

  2003cited by this paper
• Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment.

  2003cited by this paper
• Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.

  2002cited by this paper
• Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels.

  2002cited by this paper
• Androgen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume.

  2002cited by this paper
• Hormones and breathing.

  2002cited by this paper
• The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men.

  2002influential reference
• Role of Testosterone, Estradiol, and Insulin in Diet- and Exercise-Induced Reductions in Serum-Stimulated Prostate Cancer Cell Growth In Vitro

  2002cited by this paper
• Effects of androgen supplementation therapy on partial androgen deficiency in the aging male: a preliminary study

  2002cited by this paper
• The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study.

  2002cited by this paper
• Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis.

  2001cited by this paper
• Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome.

  2001cited by this paper
• Effects of androgen deficiency and replacement on prostate zonal volumes

  2001cited by this paper
• A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency.

  2001cited by this paper
• Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.

  2000cited by this paper
• Chronic Stable Angina : A Randomized , Double-Blind , Placebo-Controlled Study Low-Dose Transdermal Testosterone Therapy Improves Angina Threshold in Men With

  2000cited by this paper
• Is low serum free testosterone a marker for high grade prostate cancer?

  2000cited by this paper
• Effects of testosterone replacement in hypogonadal men.

  2000cited by this paper
• Testosterone

  2000cited by this paper
• Relationship between Endogenous Sex Hormone Levels, Lipoproteins and Coronary Atherosclerosis in Men Undergoing Coronary Angiography

  2000cited by this paper
• Hormonal predictors of prostate cancer: a meta-analysis.

  2000cited by this paper
• Experience with testosterone replacement in the elderly.

  2000cited by this paper
• Risks Versus Benefits of Testosterone Therapy in Elderly Men

  1999cited by this paper
• A critical evaluation of simple methods for the estimation of free testosterone in serum.

  1999cited by this paper
• Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men.

  1999cited by this paper
• Neck soft tissue and fat distribution: comparison between normal men and women by magnetic resonance imaging

  1999cited by this paper
• Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease.

  1999cited by this paper
• [The influence of testosterone replacement therapy on well-being, bone mineral density and lipids in elderly men].

  1998cited by this paper
• Obstructive sleep apnea due to endogenous testosterone production in a woman.

  1998cited by this paper
• Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.

  1997cited by this paper
• Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis.

  1997cited by this paper
• Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants.

  1997cited by this paper
• Androgens in men--uses and abuses.

  1996cited by this paper
• The relationship of natural androgens to coronary heart disease in males: a review.

  1996cited by this paper
• Changes in lipoprotein-lipid levels in normal men following administration of increasing doses of testosterone cypionate.

  1996cited by this paper
• Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men.

  1996cited by this paper
• Haemostatic Effects of Supraphysiological Levels of Testosterone in Normal Men

  1995cited by this paper
• A ten-year safety study of the oral androgen testosterone undecanoate.

  1994cited by this paper
• Effect of testosterone administration on upper airway collapsibility during sleep.

  1994cited by this paper
• Sustained suppression of serum LH, FSH and testosterone and increase of high‐density lipoprotein cholesterol by daily injections of the GnRH antagonist cetrorelix over 8 days in normal men

  1994cited by this paper
• Prostate volume in testosterone‐treated and untreated hypogonadal men in comparison to age‐matched normal controls

  1994cited by this paper
• Elevated serum testosterone levels and risk of hepatocellular carcinoma.

  1993cited by this paper
• Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.

  1993cited by this paper
• Androgen blockade does not affect sleep-disordered breathing or chemosensitivity in men with obstructive sleep apnea.

  1992cited by this paper
• [Androgens and the prostate].

  1991cited by this paper
• Treatment of benign prostatic hyperplasia by androgen deprivation: effects on prostate size and urodynamic parameters.

  1989cited by this paper
• Androgen and erythropoiesis: evidence for an androgen receptor in erythroblasts from human bone marrow cultures.

  1988cited by this paper
• Androgen‐Dependent Human Prostate Cancer in Nude Mice The PC‐82 Tumor Model

  1988cited by this paper
• TESTOSTERONE REPLACEMENT IN HYPOGONADAL MEN: EFFECTS ON OBSTRUCTIVE SLEEP APNOEA, RESPIRATORY DRIVES, AND SLEEP

  1985cited by this paper
• Sleep apnea, hypopnea and oxygen desaturation in normal subjects. A strong male predominance.

  1979cited by this paper
• RELATIONSHIP BETWEEN HAEMOGLOBIN AND SERUM TESTOSTERONE IN NORMAL CHILDREN AND ADOLESCENTS AND IN BOYS WITH DELAYED PUBERTY

  1978cited by this paper
• Androgens and erythropoiesis.

  1973cited by this paper
• The effect of orchiectomy and estrogens of benign prostatic hyperplasia.

  1972cited by this paper
• ANDROGENS and erythropoiesis.

  1971cited by this paper
• STUDIES ON PROSTATIC CANCER: II. THE EFFECTS OF CASTRATION ON ADVANCED CARCINOMA OF THE PROSTATE GLAND

  1941cited by this paper
• INFLUENCE OF AGE AND SEX ON HEMOGLOBIN: A SPECTROPHOTOMETRIC ANALYSIS OF NINE HUNDRED And NINETEEN CASES

  1916cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society COMMENTARY Hormonal Signaling in Prostatic

  year unknowncited by this paper

• Frailty and benign prostatic hyperplasia: The thrilling underlying impact.

  2022cites this paper
• Improvement of attention deficit/hyperactivity disorder (ADHD) in three adult men during testosterone treatment: a case series

  2022cites this paper
• Receptor-Mediated Muscle Homeostasis as a Target for Sarcopenia Therapeutics

  2021cites this paper
• Leydig‐like cells derived from reprogrammed human foreskin fibroblasts by CRISPR/dCas9 increase the level of serum testosterone in castrated male rats

  2020cites this paper
• Hypogonadism Is Associated With Increased Risks of Postoperative Complications Following Total Hip Arthroplasty.

  2020cites this paper
• Misuse of testosterone replacement therapy in men in infertile couples and its influence on infertility treatment

  2019cites this paper
• Current Hypogonadism Treatment Options

  2019cites this paper
• Men, Androgen Deficiency, and Pharmaceutical Promotion

  2017cites this paper
• Treatment of Hypogonadism: Current and Future Therapies

  2017cites this paper
• Stable Intraprostatic Dihydrotestosterone in Healthy Medically Castrate Men Treated With Exogenous Testosterone.

  2016cites this paper
• Regular exercise improves cardiac contractile activation by modulating MHC isoforms and SERCA activity in orchidectomized rats.

  2015cites this paper
• Myocardial Infarction and Stroke Risk in Young Healthy Men Treated with Injectable Testosterone

  2015cites this paper
• Review of health risks of low testosterone and testosterone administration.

  2015cites this paper
• Optimizing the Benefits of Exercise on Physical Function in Older Adults

  2014cites this paper
• Testosterone level and the effect of levodopa and agonists in early Parkinson disease: results from the INSPECT cohort

  2014cites this paper
• Risks of testosterone replacement therapy in men

  2014cites this paper
• Diagnosis and management of testosterone deficiency

  2014cites this paper
• Androgen Physiology, Pharmacology and Abuse

  2013cites this paper
• Influence of Androgens on Circulating Adiponectin in Male and Female Rodents

  2012cites this paper
• Better response with conjugate vaccine than with polysaccaride vaccine 12 months after rituximab treatment in lymphoma patients

  2012cites this paper
• CHAPTER FOURTEEN : TRANSGENDER AGING AND THE CARE OF THE ELDERLY TRANSGENDERED PATIENT

  2011cites this paper
• Diagnosis and Treatment of Sexual Dysfunctions in Late-Onset Hypogonadism

  2011cites this paper
• ACUTE AND CHRONIC TESTOSTERONE PROPIONATE REPLACEMENT THERAPY DOES NOT LEAD TO HEPATOTOXICITY IN OLD MALE WISTAR RATS

  2011cites this paper
• The Intimate Link Between Erectile Dysfunction and Heart Disease

  2010cites this paper
• Endocrine aspects of male sexual dysfunctions.

  2010cites this paper
• Testosterone Replacement Endorsed by Harvard Scientists

  2009cites this paper
• estosterone deficiency syndrome : Treatment and cancer risk

  2009cites this paper
• Testosterone deficiency syndrome: treatment and cancer risk.

  2009cites this paper
• Men, Androgen Deficiency, and Pharmaceutical Promotion—Reply

  2009cites this paper
• Evaluation of late-onset hypogonadism (andropause) treatment using three different formulations of injectable testosterone.

  2009cites this paper
• Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression?

  2009cites this paper
• Temporal trends in testosterone levels and treatment in older men

  2009cites this paper
• Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review

  2009cites this paper
• Treatment of symptomatic androgen deficiency: results from the Boston Area Community Health Survey.

  2008cites this paper
• Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample.

  2008cites this paper
• Optimizing Testosterone Levels in Aging Men

  2008cites this paper
• The role of vitamin E in reversing bone loss

  2008cites this paper
• Behandeling met androgenen: dé remedie tegen spierzwakte bij oudere mannen? Een meta-analyse

  2008cites this paper
• The Transsexual Male

  2008cites this paper
• Burden of dizziness and vertigo in the community.

  2008cites this paper
• The use of testosterone in the treatment of chronic postvasectomy pain syndrome: case report and review of the literature.

  2007cites this paper
• Testosterone therapy and obstructive sleep apnea: is there a real connection?

  2007cites this paper
• Androgen Treatment and Muscle Strength in Elderly Men: A Meta‐Analysis

  2006cites this paper
• Testosterone supplementation and the prostate: a review of the safety issue

  2006cites this paper
• Looking forward in geriatric anxiety and depression: implications of basic science for the future.

  2005cites this paper